Inhibikase Therapeutics Ownership | Who Owns Inhibikase Therapeutics?
Inhibikase Therapeutics Ownership Summary
Inhibikase Therapeutics is owned by 0.05% institutional investors, and 99.95% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.28% of its assets in Inhibikase Therapeutics shares.
IKT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Inhibikase Therapeutics | 0.05% | - | 99.95% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | 1 | -94.12% | 13,802 | -99.69% | - | 0.02% | - | -100.00% | 1 | -50.00% |
| Mar 31, 2023 | 17 | -10.53% | 4,421,111 | 206.88% | 16 | 49.22% | 7 | -22.22% | 2 | -60.00% |
| Dec 31, 2022 | 19 | -13.64% | 1,440,673 | -52.69% | 5 | 3.92% | 9 | 80.00% | 5 | 25.00% |
| Sep 30, 2022 | 22 | 10.00% | 3,045,355 | -9.10% | 12 | 6.84% | 5 | -50.00% | 4 | - |
| Jun 30, 2022 | 20 | -13.04% | 3,350,331 | -21.64% | 13 | 4.62% | 10 | 25.00% | 4 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.28M | 3.28% | 2.28M |
| Vanguard Institutional Extnd Mkt Idx Tr | 483.35K | 0.70% | 437.10K |
| Extended Equity Market Fund K | 53.76K | 0.08% | 53.76K |
| Vanguard Balanced Index Inv | 44.36K | 0.06% | 44.36K |
| Fidelity Extended Market Index | 36.14K | 0.05% | -238.00 |
| Vanguard Instl Ttl Stk Mkt Idx InstlPls | 33.54K | 0.05% | 33.54K |
| NT Ext Equity Mkt Idx Fd - NL | 32.64K | 0.05% | 30.45K |
| NT Ext Equity Mkt Idx Fd - L | 29.91K | 0.04% | 27.29K |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 25.87K | 0.04% | 24.10K |
| Northern Trust Extended Eq Market Idx | 2.62K | 0.04% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 21, 2024 | Bellini Roberto | - | Buy | $2.00M |
| Oct 21, 2024 | Kush Arvind | - | Buy | $198.65K |
| Oct 21, 2024 | Munshi Amit | - | Buy | $500.05K |
| Aug 16, 2022 | Werner Milton H. | President and CEO | Buy | $4.00K |
| May 27, 2022 | Werner Milton H. | President and CEO | Buy | $4.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 3 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
IKT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools